The company set a new benchmark for R&D investment, allocating approximately 2.80 billion RMB ($416 million USD), an 11.87 percent annual increase from the previous year
to the same exact depth within that channel (since channels start closing almost immediately, and close at inconsistent rates amongst the channels)
For the Dispensing Pharmacy How is the compounded medication prepared, and what concentration am I receiving
Boehringers effective IP barrier is therefore not 25 patents for Combivent alone it is 18 shared device patents functioning as a franchise-wide moat across four respiratory products generating combined revenues in the multi-billion dollar range
Aetna : Wegovy is available with some plan coverage, subject to prior authorization
In a study of 195 patients with idiopathic small fiber neuropathy, 11 44% had an elevated serum level, but no evidence of sarcoidosis was seen on further testing, which included computed tomography of the chest in 29 patients